Skip to main content
Clinical Trials/NCT03665298
NCT03665298
Withdrawn
Not Applicable

Needle-X: Usability Testing of a Smartphone Application

NYU Langone Health1 site in 1 countryFebruary 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Opioid Dependence
Sponsor
NYU Langone Health
Locations
1
Primary Endpoint
Feasibility of Needle-X application
Status
Withdrawn
Last Updated
6 years ago

Overview

Brief Summary

Mobile health interventions offer a longitudinal approach to reducing the burden of substance use disorders and may stem the rise of the opioid overdose epidemic. Smartphone applications are one of the most popular mobile phone features nationally, among patients in addiction treatment, and among criminal justice involved (CJI) patients enrolled in addiction treatment. This research conducted at Bellevue Hospital's inpatient detoxification program established attitudes and self-reported behaviors favorable to theoretical smartphone applications addressing opioid use, HIV, and HCV prevention and management strategies. This study aims to assess the feasibility and usability of a smartphone application to enhance access to sterile needles, naloxone overdose kits, and addiction treatment programs in New York City.

Registry
clinicaltrials.gov
Start Date
February 2019
End Date
November 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Fluent in spoken and written English;
  • Meets or has previously met DSM-5 criteria for current opioid use disorder, of at least moderate severity;
  • Owns or has owned a smartphone

Exclusion Criteria

  • Any patient who does not meet the inclusion criteria as above, is clinically unstable per the unit admitting physicians, refuses to participate in the study, or is cognitively impaired.

Outcomes

Primary Outcomes

Feasibility of Needle-X application

Time Frame: 12 Months

number of patients enrolled, as this study will include a single interaction, at which point the patient will no longer be part of the study.

Study Sites (1)

Loading locations...

Similar Trials